XML 60 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
FINANCIAL INFORMATION BY QUARTER (UNAUDITED) (Tables)
12 Months Ended
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Financial Information by Quarter

 

 

2017 for Quarter Ended

 

 

December 31

 

 

September 30

 

 

June 30

 

 

March 31

 

 

(in thousands)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product, net

$

57,277

 

 

$

45,954

 

 

$

35,011

 

 

$

16,342

 

Total revenues

 

57,277

 

 

 

45,954

 

 

 

35,011

 

 

 

16,342

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales (excluding amortization of in-licensed rights)

 

3,546

 

 

 

3,078

 

 

 

505

 

 

 

224

 

Research and development

 

44,441

 

 

 

34,239

 

 

 

58,908

 

 

 

29,119

 

Selling, general and administrative

 

32,221

 

 

 

28,176

 

 

 

36,069

 

 

 

26,216

 

Settlement and license charges

 

 

 

 

25,588

 

 

 

2,839

 

 

 

 

Amortization of in-licensed rights

 

216

 

 

 

780

 

 

 

29

 

 

 

28

 

Total cost and operating expenses

 

80,424

 

 

 

91,861

 

 

 

98,350

 

 

 

55,587

 

Operating loss

 

(23,147

)

 

 

(45,907

)

 

 

(63,339

)

 

 

(39,245

)

Other (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest (expense) income and other, net

 

(2,693

)

 

 

184

 

 

 

184

 

 

 

335

 

Gain from sale of Priority Review Voucher

 

 

 

 

 

 

 

 

 

 

125,000

 

Total other (loss) income

 

(2,693

)

 

 

184

 

 

 

184

 

 

 

125,335

 

(Loss) income before income tax (benefit) expense

 

(25,840

)

 

 

(45,723

)

 

 

(63,155

)

 

 

86,090

 

Income tax (benefit) expense

 

(1,842

)

 

 

2,011

 

 

 

(109

)

 

 

2,000

 

Net (loss) income

$

(23,998

)

 

$

(47,734

)

 

$

(63,046

)

 

$

84,090

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic (loss) earnings per share

$

(0.37

)

 

$

(0.78

)

 

$

(1.15

)

 

$

1.53

 

Diluted (loss) earnings per share

$

(0.37

)

 

$

(0.78

)

 

$

(1.15

)

 

$

1.50

 

Weighted average number of shares of common stock used in calculating:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic (loss) earnings per share

 

64,277

 

 

 

61,528

 

 

 

54,976

 

 

 

54,850

 

Diluted (loss) earnings per share

 

64,277

 

 

 

61,258

 

 

 

54,976

 

 

 

56,012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 for Quarter Ended

 

 

December 31

 

 

September 30

 

 

June 30

 

 

March 31

 

 

(in thousands)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product, net

$

5,421

 

 

$

 

 

$

 

 

$

 

Total revenues

 

5,421

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost and operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales (excluding amortization of in-licensed rights)

 

101

 

 

 

 

 

 

 

 

 

 

Amortization of in-licensed rights

 

29

 

 

 

 

 

 

 

 

 

 

Research and development

 

70,749

 

 

 

34,349

 

 

 

44,348

 

 

 

38,826

 

Selling, general and administrative

 

22,937

 

 

 

22,184

 

 

 

17,752

 

 

 

20,876

 

Total operating expenses

 

93,816

 

 

 

56,533

 

 

 

62,100

 

 

 

59,702

 

Operating loss

 

(88,395

)

 

 

(56,533

)

 

 

(62,100

)

 

 

(59,702

)

Other (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense and other, net

 

(57

)

 

 

(209

)

 

 

(201

)

 

 

(68

)

Total other loss

 

(57

)

 

 

(209

)

 

 

(201

)

 

 

(68

)

Net loss

$

(88,452

)

 

$

(56,742

)

 

$

(62,301

)

 

$

(59,770

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share—basic and diluted

$

(1.62

)

 

$

(1.18

)

 

$

(1.35

)

 

$

(1.31

)

Shares used in per share calculations—basic and diluted

 

54,619

 

 

 

48,254

 

 

 

46,157

 

 

 

45,697